Original Publication Date: 11 April, 2016
Publication / Source: Future Oncology
Authors: Steding CE
Breast cancer continues to be of critical clinical significance. Even after years of successful advancements in therapeutic options, it remains the second leading cause of cancer-related death in women. An estimated 40,000 women are expected to succumb to advanced, metastatic disease within the next calendar year . Although the rates of breast cancer-related deaths have been declining, the high incidence of both tumor recurrence and metastasis make finding new and creative treatment methodologies essential to combating this complex, heterogeneous disease more effectively.